@XeniaParisi@EShuyu@PaulYoungMD1 Good morning, It has been couples of weeks that I cannot find the meeting links. Can you please help? What Am I missing?
🩸Burkitt lymphoma with granulomatous background is a rare and underrecognized variant that expands the list of lymphomas with granulomatous presentation (mainly classic Hodgkin lymphoma and T-cell lymphomas).
🩸Few of these cases have been reported in the litterature.
🩸These seem to be associated with EBV positivity even though they are non-endemic clinically.
Photo➡️https://t.co/MZyJDmhro3
#Hemepath #lymsm #pathX #Medx #MedTwitter #PathTwitter #Surgpath #GIpath #SoMe
See you tomorrow on zoom
12 pm EST
Meeting ID: 861 0435 1759
Passcode: 198628
I’m told this will be broadcast live on @facebook and @YouTube too 😅
#hemepath
Thank you @mannanrifat03 🙏🏻
Some light #hemepat#leusm reading for your Sunday AM. We hope you find this helpful.
https://t.co/PE6Wiymf4n
@BloodReviews w/ @CLachowiez and Daniel Chandra
Came across this wonderful IHC algorithm for when to do FISH in suspected ALCL cases at #SH23 today.
The source for the paper Feldman AL, st al Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2022. PMID: 35941721.
The #SocforHemepath#USCAP2021 Companion Meeting material is now available on demand!! All star line up on clonal hematopoiesis including: @PapaemmanuilLab, Dr. Hasserjian, Dr. Godley & @jaiswalmdphd!
Hosted by Dr. Duncavage and Dr. George
https://t.co/6OiX4jW3DZ #hemepath
. @FVega957 opening the #SH23 workshop this morning.
Practical algorithm for classification of peripheral T cell lymphomas #PTCL#lymsm
May be easier said than done 😉
#SH23
You can watch the recording of the first episode of season 2 on Ph-like ALL and ETP ALL here https://t.co/9ya8VMCTYu #hemepath#leusm
It’s much better than MOC 😉…@AaronGoodman33
Thrilled to share our comprehensive guide on using #flowcytometry in the Dx of chronic myeloid neoplasms & post-AML clonal hematopoiesis. Co-authored w/the fabulous @SibaElHussein
full text and schematics👇🏻#hemepath#mdssm @ElsevierNews https://t.co/L2RjHj58yF
Dx of LU cases
C1: HGBCL or DLBCL w/ aggressive features
C2: Marginal zone lymphoma
C3: Atypical paracortical hyperplasia (morphology similar to AITL with PD1+ BCL6 pos. However, no clonality, flow neg, h/o drug reaction in skin)
C4: Histiocytic sarcoma
C5: Extranodal MZL
Just online! ALK-positive histiocytosis radiologically mimicking a meningioma; a challenging diagnosis in disguise of a lymphohistiocytic lesion on histopathology. @GauravGoyalMD@RatiChkheidze@UABPathology
https://t.co/vLWzB53Brg
How I use p53 IHC to
screen for #TP53 mutation status in #AML#MDS
Recognize two abnormal patterns: overexpression (3+) & null (complete absence of staining in all neoplastic cells)
Only 3+ nuclei count for aberrant overexpression (don’t count 1+/ 2+) #hemepath#pathtwitter
Kudos to camp TCL1 FISH. high WBC + morphology (cytoplasmic Blebs): think T-prolymphocytic leukemia, defined by TCL1 rearrangement (inv 14q). Coincidentally 🔥 off the press in @Nature on the significance of Blebs https://t.co/sGCLDdLNIe by @MuthrNaturzSon and team #hemepath